See All Slides - tctmd.com

Slides

Presentation TCT 2013

Echocardiographic Imaging Primer for TAVR II. Intraprocedural Planning

Presenter: Sherif Nagueh

October 30, 2013

Presentation TCT 2013

Endovascular Solutions for the Ascending Aorta and the Future Potential of Technology Synergies with Transcatheter Aortic Valves

Presenter: Christoph Nienaber

October 30, 2013

Presentation TCT 2013

New Devices and Techniques in Carotid Stenting: Clinically Meaningful?

Presenter: Sumaira Macdonald

October 30, 2013

Presentation TCT 2013

How Did I Treat This Patient (And How Did It Turn Out)?

Presenter: Wen-Lieng Lee

October 30, 2013

Presentation TCT 2013

Carotid Stenting Randomized Trials Redux: ACST2, SPACE 2, and CREST2

Presenter: Alison Halliday

October 30, 2013

Presentation TCT 2013

MitraClip Patient Selection for FMR II. Identifying Appropriate Patients

Presenter: Anita Asgar

October 30, 2013

Presentation TCT 2013

Hybrid Strategies for Treatment of Aortic Arch Pathologies

Presenter: Wilson Szeto

October 30, 2013

Presentation TCT 2013

Case Presentation: Paravalvular AR After TAVR

Presenter: Femi Philip

October 30, 2013

Presentation TCT 2013

The Great Debate: Does It Make Sense to Search and Destroy Focal Vulnerable Plaque? No! A Futile, Expensive, and Risky Enterprise!

Presenter: John Ambrose

October 30, 2013

Presentation TCT 2013

Case #2 – An Unusual Solution for an Unusual Problem

Presenter: Joelle Kefer

October 30, 2013

Advertisement

Slides

Echocardiographic Imaging Primer for TAVR II. Intraprocedural Planning

Endovascular Solutions for the Ascending Aorta and the Future Potential of Technology Synergies with Transcatheter Aortic Valves

New Devices and Techniques in Carotid Stenting: Clinically Meaningful?

How Did I Treat This Patient (And How Did It Turn Out)?

Carotid Stenting Randomized Trials Redux: ACST2, SPACE 2, and CREST2

MitraClip Patient Selection for FMR II. Identifying Appropriate Patients

Hybrid Strategies for Treatment of Aortic Arch Pathologies

Case Presentation: Paravalvular AR After TAVR

The Great Debate: Does It Make Sense to Search and Destroy Focal Vulnerable Plaque? No! A Futile, Expensive, and Risky Enterprise!

Case #2 – An Unusual Solution for an Unusual Problem

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content